Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | +1.77% | +3.57% | +32.39% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.39% | 231.94Cr | |
+11.75% | 3,09600Cr | |
+11.38% | 8.54TCr | |
+6.05% | 7.71TCr | |
-13.53% | 5.43TCr | |
-22.84% | 4.79TCr | |
+24.58% | 4.77TCr | |
+18.76% | 4.22TCr | |
+65.58% | 3.81TCr | |
-9.25% | 2.47TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cowen Adjusts Price Target on Cellebrite DI to $10 From $13, Keeps Outperform Rating